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Abstract
Background: Identification of the Mycobacterium tuberculosis complex organisms to the species level is important
for diagnostic, therapeutic and epidemiologic perspectives. Indeed, isolates are routinely identified as belonging to
the M. tuberculosis complex without further discrimination in agreement with the high genomic similarity of the
M. tuberculosis complex members and the resulting complex available identification tools.
Findings: We herein develop a pyrosequencing assay analyzing polymorphisms within glpK, pykA and gyrB genes
to identify members of the M. tuberculosis complex at the species level. The assay was evaluated with 22 M.
tuberculosis,2 1M. bovis,3M. caprae,3M. microti,2M. bovis BCG, 2 M. pinnipedii,1M. canettii and 1 M. africanum
type I isolates. The resulted pyrograms were consistent with conventional DNA sequencing data and successfully
identified all isolates. Additionally, 127 clinical M. tuberculosis complex isolates were analyzed and were
unambiguously identified as M. tuberculosis.
Conclusion: We proposed a pyrosequencing-based scheme for the rapid identification of M. tuberculosis complex
isolates at the species level. The assay is robust, specific, rapid and can be easily introduced in the routine activity.
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Background
The Mycobacterium tuberculosis complex (MTC)
includes M. tuberculosis, M. bovis and BCG-derived
clones, M. africanum, M. canettii, M. microti, M. caprae
and M. pinnipedii [1]. Recently, an eight member named
Mycobacterium mungi was identified in banded mon-
gooses (Mungos mungo) in Botswana [2]. While there is
variable host-specificity among the different MTC mem-
bers, every species, but M. mungi, has been implicated in
human tuberculosis with M. tuberculosis being the most
common pathogen [3-6]. The exact contribution of each
species in human disease may be underestimated due to
the limited capacity of laboratories to identify MTC iso-
lates at the species level in routine practice. Indeed, phe-
notypic methods are time-consuming and the results are
difficult to interpret. Molecular assays are hampered by
the high genetic similarity reflected by the complete con-
servation of the 16S rRNA and rpoB genes of the MTC
members [7,8]. This situation indeed, led to propose that
the various MTC species would be more accurately
described as ecotypes [9]. Despite the high degree of
nucleotide sequence homology, some genomic markers
such as pncA, mpt40, hupB, gyrB and wbbl1genes in addi-
tion to the regions of difference (RD) have been success-
fully used for the differentiation of MTC members
through direct analysis such as in spoligotyping or after
enzymatic digestion of PCR products [10-16]. Neverthe-
less, most of these techniques allow only partial discrimi-
nation between the MTC species and are too fastidious
to be implemented in the routine practice of microbiol-
ogy laboratories. The Genotype MTBC (Hain Lifescience,
GmbH, Nehren, Germany) is a commercial DNA-strip
based assay identifying MTC species through the detec-
tion of gyrB gene single nucleotide polymorphisms
(SNPs) and RD1 [17]. The test is easy to use, but failed to
identify M. canettii and M. pinnipeddii [17].
Pyrosequencing is a real-time non-electrophoretic
DNA sequencing technique that can be easily adapted
for routine use in the clinical microbiology laboratory.
This technique was successfully used for the identifica-
tion of non-tuberculous mycobacteria, identification of
the Beijing family of M. tuberculosis and detection of
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here developed a pyrosequencing assay for the rapid
identification of the MTC species based on polymorph-
isms within the glpK, pykA and gyrB genes.
Methods
MTC isolates
A set of 8 reference MTC isolates and 47 M. africanum
type 2 and human and animal clinical isolates representa-
tive of all MTC species (excluding M. mungi and
M. africanum type II) after molecular identification as
previously described [21] was used in this study
[15,16,20]. Maria Laura Boschiroli (ANSES, Maisons-
Alfort, France) graciously provided DNA extracts of
MTC organisms isolated from different animal species
(cattle, badger, cat, dog, sea lion, wild boar, wild deer,
marmoset and chimpanzee). In addition, 127 clinical
MTC organisms identified using ITS-real time PCR were
analyzed (Additional file 1). These strains were isolated
at the microbiology laboratory of Farhat Hached Hospi-
tal, Sousse, Tunisia and the mycobacteria reference
laboratory of the Institut Hospitalier Universitaire POL-
MIT, Marseille, France. This study involves mycobacteria
isolated from animals and from patients as a part of the
routine diagnostic activity of laboratories and does not
involve animals or patients themselves. No informed con-
sent was obtained from individuals in agreement with
French law, as the study concerns only microbiota and
not the individuals themselves.
glpK and pykA gene analyses
The sequence of the glpK and pykA genes of M. tuberculo-
sis H37Rv (Genes ID: 885280, 885501), H37Ra (Genes ID:
5214476, 5215168), F11(Genes ID: 5224418, 5222312),
KZN1435 (Genes ID: 8164550, 8160651) and CDC1551
(Genes ID: 922690, 924212), M. bovis AF2122 (Genes ID:
1093713, 1092578), M. bovis BCG Tokyo (Genes ID:
7563752, 7560567) and M. bovis BCG Pasteur (Genes ID:
4698362, 4695734) were downloaded from GenBank and
aligned using the Clustal software (http://www.clustal.org).
In addition, specific primers were designed using the
NCBI Primer BLAST (http://www.ncbi.nlm.nih.gov/tools/
primer-blast/) for amplification and conventional sequen-
cing of both genes in M. tuberculosis (N = 10), M. bovis
(N = 10), M. caprae (N = 3), M. microti (N = 3), M. bovis
BCG (N = 2), M. pinnipedii (N = 2), M. canettii (N = 1),
and M. africanum type I (N = 1) isolates (Table 1). PCR
reaction was performed in a final volume of 50 μl compris-
ing 22.75 μl of water, 10 μl of 5x Q-buffer (Qiagen, Cour-
taboeuf, France), 5 μl of 10x buffer, 200 mM of each
dDNTP, 1 μl of forward and reverse primers (10 pmol/μl),
2.5 U of hotstar Taq polymearse (Qiagen) and 5 μlo ft e m -
plate DNA. Negative controls consisting of reaction mix
w i t h o u tD N Aw e r ea d d e di ne a c hP C Rr u n .T h eP C R
conditions consisted of enzyme activation at 95°C for 15
min, 40 cycles of 30 s at 94°C, 2.5 min at 60°C, 1 min at
72°C and a final elongation at 72°C for 5 min. Sequencing
was performed using the BigDye Terminator v1.1 Cycle
Sequencing kit (Applied Biosystems, Courtaboeuf, France)
and the 3100 genetic analyser (Applied Biosystems) [21].
Sequences were assembled and analysed with the Seqscape
software (Applied Biosystems).
Pyrosequencing analysis
After analysis of the glpK and pykA gene sequences, MTC
species-specific polymorphic regions were targeted for
pyrosequencing [15]. To allow discrimination between all
MTC members, single nucleotide polymorphisms (SNPs)
within the gyrB gene were also used [13]. Specific primers
were designed using the PSQ assay (Qiagen) (Table1). In a
first step, simplex PCR reactions were performed as
described above with 1-min of elongation instead of
2.5 min. PCR products were then subjected to simplex
pyrosequencing analysis using the PyroMark Q96 ID Sys-
tem (Qiagen) as previously described [18]. SNP analyses
were performed using the SNP program of the PyroMark
Q96 ID software. Sequencing analysis was realized using
the sequencing program with a 6(GATC) dispension
order. Secondly, we performed multiplex PCR and pyrose-
quencing reactions with the same conditions as for sim-
plex analysis. The choice of the gene fragments to be
simultaneously analyzed was dictated by the PyroMark
Q96 ID software so that polymorphic regions did not
overlap. For multiplex SNP analysis, two sequencing pri-
mers were hybridized either to a single or two PCR ampli-
fied loci.
Specificity testing
A set of clinical isolates of non tuberculous mycobacteria
(Mycobacterium smegmatis, Mycobacterium immuno-
genum, Mycobacterium bolletii, Mycobacterium chelonae,
Mycobacterium abscessus, Mycobacterium massillense,
Mycobacterium avium and Mycobacterium intracellulare)
and other bacteria (Escherichia coli, Klebsiella pneumo-
niae, Enterococcus feacalis, Salmonella enterica, Proteus
mirabilis, Proteus vulgaris, Pseudomonas aeruginosa,
Citrobacter freundii and Stenotrophomonas maltophilia)
were tested on the pyrosequencing analysis to assess the
specificity of the assay. Isolates were identified by sequen-
cing the 16S rRNA or the rpoB gene and/or using matrix-
assisted laser desorption ionization time-of-flight mass
spectrometry (Bruker Daltonics, Wissembourg, France)
[22].
Results and discussion
The pykA (encoding for the pyruvate kinase) and glpK
(encoding for the glycerol kinase) genes were previously
analyzed to disclose the genetic basis of difference in the
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M. bovis in comparison with other MTC species [23,24].
T h ea u t h o r sr e p o r t e das p e c i f i cg e n es t r u c t u r ef o rM.
tuberculosis, M. bovis and M. bovis BCG but this particu-
larity has not been furtheru s e df o ri d e n t i f y i n gM T C
organisms. In our study, we extended this previous obser-
vation to all MTC species and a larger collection of clini-
cal isolates in the perspective of MTC member’s
identification.
In PCR-based experiments all negative controls
remained negative and no PCR products were obtained
when testing non-tuberculous mycobacteria and other
bacteria confirming the specificity of the primer sets used.
After alignment of the glpK and pykA gene sequences
herein achieved and those downloaded from GenBank, we
observed MTC species-specific signatures within the glpK
gene. Four silent SNPs were found at nucleotide (nt) posi-
tion 279 (A®G), 336 (T®C), 435 (T®A) and 1,497
(T®C) specifically within M. canettii. Insertion of one and
three guanine at nt 573 was identified in M. microti and
M. bovis BCG, respectively. M. bovis reference isolates also
shared the same frameshift as M. microti at nucleotide 573
in addition to a G®C SNP at nt 779, but these poly-
morphisms were not found in the human and animal clin-
ical M. bovis isolates (N = 10), in agreement with a
previous study [23]. Thus, these SNPs further were not
considered as M. bovis specific feature for subsequent ana-
lysis. M. pinnipedii specifically exhibits a G®A SNP at nt
845 and M. tuberculosis aC ®T SNP at nt 1,397. Exclud-
ing M. bovis reference strains, no specific feature in the
glpK gene was observed within M. bovis and M. caprae
isolates. As for the pykA gene, a unique G®TS N Pa tn t
660 was commonly detected in M. bovis, M. caprae,
M. microti and M. pinnipedii. This SNP substitutes gluta-
mic acid with aspartic acid at codon 220, resulting in an
inactive pyruvate kinase and the inability of M. bovis to
use glycerol as a carbone source [23,24]. By analyzing a
larger collection of isolates, our results confirmed the pre-
sence of this SNP within M. bovis and provide the novel
evidence for its occurrence also in M. caprae and
Table 1 Sequencing and pyrosequencing primers used in this study
Gene Method Primer name Primer sequence (5’ -3 ’) Product size (bp)
glpK Sequencing glpk-Forward CGACCGCGACTTCCGCAAGT 1,698
glpk-Reverse AACATGTCCGCACGCTCGGG
glpk-Internal 1 TGATCCGCCGCAAGGCG
glpk-Internal 2 CTGGCGGCAAGCTGCAGT
glpk-Internal 3 GCTAAACCCGTGTACGCGCT
glpk-Internal 4 ATCGCGGTGACCGGCTC
Pyrosequencing glpk-573-F AGAACGGCGACGCATTGT 106
glpk-573-R Biotin- CTGGCGTTGGTTACATCGGT
glpk-573-Seq GGTGTTGTGGAATCTGA
glpk-845-F Biotin- GGGGAGGCGAAAAACACCTAT 52
glpk-845-R CGGTGTTCAGCAGCAGAAAA
glpk-845-Seq AGAAAATTGCCGGTC
glpk-1379-F TCACCGGCAACGACCTGT 126
glpk-1379-R Biotin- AGAACCCGACCGCCAAGC
glpk-1379-Seq GACCACCGCACTAGG
pykA Sequencing pyka-Forward TACCGCCGTCGCGACTATGC 1,540
pyka-Reverse TCGCAAGCGACCTGTTCACCG
pyka-Internal 1 CACGATCGGGTGTCCACC
pyka-Internal 2 TGGCCGGTGACCGGGTG
pyka-Internal 3 TCGATGGCGCCGACGCG
pyka-Internal 4 ATGCTGTCCGGGGAAACCT
Pyrosequencing pyka-Forward GAACTGGTCCACGAGGTGA 100
pyka-Reverse Biotin- GCACGATCGCTTCGAGATT
pyka-Sequencing CGGTGATCGCCAAGCT
gyrB Pyrosequencing gyrB-6307-F Biotin- CGCAAGCTACTGAAGGACAAGG 113
gyrB-6307-R TTGGTCTGGCCCTCGAACT
gyrB-6307-seq CCTTCACCGAGATCA
gyrB-6406-F AAGACCAAGTTGGGCAACAC 121
gyrB-6406-R Biotin- ACACAGCCTTGTTCACAACG
gyrB-6406-seq TGTGCAGAAGGTCTGTAA
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study [23]. Accordingly, M. bovis, M. caprae and M. pinni-
pedii are all characterized by the inability to use glycerol
and require pyruvate for growth [24]. We were not able to
sequence glpK and pykA genes in M. africanum,n e v e r t h e -
less positive results were obtained by pyrosequencing ana-
lysis (see below). Polymorphic regions within the glpK and
pykA genes were targeted for MTC species identification
using a pyrosequencing approach. Since no specific signa-
ture was obtained for M. bovis and M. caprae,w ec o m -
bined previously described SNP of the gyrB gene to allow
complete MTC discrimination [15]. In a first step, the
assay was evaluated with the well characterized MTC spe-
cies (N = 55). The pyrograms obtained from simplex and
multiplex data were consistent with the results obtained
by conventional DNA sequencing and correctly identifies
MTC isolates including 22 M tuberculosis,2 1M. bovis,2
M. bovis BCG, 3 M. caprae,3M. microti,2M. pinniped-
dii,1M. canettii and 1 M. africanum type I. Accordingly,
we propose a generalized diagram for the rapid identifica-
tion of the MTC species (Figure 1). In a first step, multi-
plex amplification and pyrosequencing analysis of the
glpK1379 and pykA660 nt positions in one reaction tube
provide four different pyrograms: T/T and G/G specific
Figure 1 Ap r o p o s e ds c h e m ef o rMycobacterium tuberculosis species identification by pyrosequencing.
1 Genes analysed by multiplex
SNP program.
2Gene analysed by sequencing program.
3Genes analysed by simplex SNP program.
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num type I, C/C and G/G specific for M. bovis BCG and
M. canettii (group 1) and C/C and T/T specific for
M. bovis, M. caprae, M. microti and M. pinnipedii (group
2). If pyrogram of group 1 is obtained, sequencing of the
glpK573 may discriminate between M. bovis BCG and
M. canettii. In the case where pyrogram of group 2 is
obtained, analysis of the gyrB6406 SNP may specifically
identifies M. bovis ( g e n o t y p eC / C )f r o mt h er e m a i n i n g
group 2 species (genotype T/T). M. pinnipedii can be
identified by SNP analysis of the glpK845 (genotype A/A),
M. caprae by SNP analysis of the gyrB6307 and M. microti
by sequencing the glpK573. These steps can be done in
parallel in order to minimize the delay for final identi-
fication of any MTC species. A total of 127 MTC clinical
isolates were tested following this scheme and were unam-
biguously identified as M. tuberculosis.
Our proposed scheme allows in one step the specific
identification of M. tuberculosis, the leading cause of
human tuberculosis worldwide and M. africanum type I,
an important cause of human tuberculosis in west
Africa [6,25]. M. bovis, an important zoonotic tuberculo-
sis agent and M. bovis BCG a safe vaccine exceptionally
responsible for disseminated disease in immuno-com-
promised vaccinated neonates and bladder cancer-
patients, could be unambiguously identified in a second
reaction after excluding M. tuberculosis and M. africa-
num type I [26,27]. The remaining MTC species are less
common in human disease and their identification using
specific genomic marker described here could be direc-
ted by epidemiologic data.
The ability of rapid and accurate identification of
MTC members has an important impact both for public
health and veterinary facilities. Although a few patients
infected with M. bovis have been treated by antibiotic
regimens incorporating the pyrazinamide, the natural
resistance of these species to pyrazinamide makes pyra-
zinamide generally not recommended for treating such
patients [10]. Moreover, it can help epidemiologists and
health care professionals to measure the relative contri-
bution of each MTC species in human and animal dis-
ease, to identify specific MTC-specie outbreak and to
rapidly intercept the impact of the zoonotic transmis-
sion particularly in case of M. bovis infections so that
appropriate control measure could be undertaken.
Conclusion
Pyrosequencing analysis of the glpK, pykA and gyrB
genes provides a robust and easy tool for the rapid iden-
tification of all MTC species that can be easily intro-
duced in the routine laboratory activity, just requiring
basics skills in PCR. The assay allows the simultaneous
analyses of up to 96 isolates within 10 to 20 min after a
4-hour DNA extraction and PCR amplification rounds
comprising of 3 different PCRs, and 7 different pyro-
sequencing steps which can be run in parallel.M o r e -
over, pyrosequencing has several advantages compared
to other molecular methods: it determines the exact
sequence thereby providing the same accuracy as con-
ventional sequencing methods, the technique dispenses
with the need for labeled nucleotides, labeled primers
and electrophoresis.
Additional material
Additional file 1: List of M. tuberculosis complex isolates used in
this study. The table lists from left to right the reference number, the
identification at the species level, the source, the geographical origin,
and the genotype according to Multispacer Sequence Typing of the
isolates used in this work.
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